Review
Copyright ©The Author(s) 2022.
World J Diabetes. Sep 15, 2022; 13(9): 668-682
Published online Sep 15, 2022. doi: 10.4239/wjd.v13.i9.668
Figure 3
Figure 3 Type 2 diabetes and nonalcoholic fatty liver disease are both associated with multiple metabolic and cardiovascular morbidities. Furthermore, the presence of one increases the risk to develop the other and thus exacerbating the overall prognosis. HCC: Hepatocellular carcinoma; NAFLD: Nonalcoholic fatty liver disease.